In unconjugated hyperbilirubinemia, the risk of kernicterus increases with the use of –
**Core Concept**
Conjugated vs unconjugated hyperbilirubinemia refers to the type of bilirubin that is elevated in the blood. Unconjugated hyperbilirubinemia occurs when there is an increase in the amount of unconjugated (indirect) bilirubin, which has not yet been processed by the liver. This condition is often associated with hemolytic disease of the newborn, breast milk jaundice, or Gilbert syndrome. Kernicterus is a neurological condition that can occur in newborns with severe unconjugated hyperbilirubinemia, leading to brain damage.
**Why the Correct Answer is Right**
The risk of kernicterus increases with the use of sulfonamides because they displace bilirubin from albumin, leading to a higher free bilirubin concentration. This is known as the "sulfonamide displacement effect." The binding of bilirubin to albumin is reduced, causing more bilirubin to be transported to the brain, where it can cause damage. This effect is particularly concerning in newborns with unconjugated hyperbilirubinemia, as it can lead to kernicterus.
**Why Each Wrong Option is Incorrect**
* **Option A:** Phenobarbital is actually used to treat unconjugated hyperbilirubinemia by inducing the enzymes responsible for bilirubin conjugation, making this option incorrect.
* **Option B:** Folic acid has no known effect on bilirubin levels or the risk of kernicterus, making this option incorrect.
* **Option C:** This option is incomplete, but we can assume it is incorrect based on the context.
**Clinical Pearl / High-Yield Fact**
When managing a newborn with unconjugated hyperbilirubinemia, it is essential to be aware of medications that can displace bilirubin from albumin, such as sulfonamides. This is critical to prevent kernicterus and ensure the best possible outcome for the newborn.
**Correct Answer:** C.